The Populist Discourse of the Hungarian Prime Minister: The Case Study of Gyöngyöspata and Migration Crisis
Politics in Central Europe · 2023
DOI: 10.2478/pce-2023-0001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Politics in Central Europe, 2023. Verfasst von Tofig Ismayilzada. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 3.0).
Abstract (Originalsprache)
The study aims to analyse if the Hungarian prime minister attempted to portray an ‘other’ image of the Roma ethnic minority group during the segregated primary school conflict in Gyöngyöspata. Moreover, the study will explore the Hungarian prime minister’s discourse on the migration crisis to understand if Viktor Orbán adopted the same communication strategy as in the Gyöngyöspata conflict. Comparing the two cases will allow us to identify the key similarities and differences in the discourse adopted by the Hungarian prime minister in different events. This research uses the qualitative content analysis methodology to examine the collected data. Besides this, the study concludes that Viktor Orbán attempted to portray an ‘other’ image of the Roma ethnic minority group during the Gyöngyöspata conflict. This study aims to fill a gap in the literature by analysing the Hungarian prime minister’s discourse on the Gyöngyöspata conflict and comparing his discourse on both cases.
Zitieren
APA
Ismayilzada, T. (2023). The Populist Discourse of the Hungarian Prime Minister: The Case Study of Gyöngyöspata and Migration Crisis. Politics in Central Europe. https://doi.org/10.2478/pce-2023-0001
Vancouver
Ismayilzada T. The Populist Discourse of the Hungarian Prime Minister: The Case Study of Gyöngyöspata and Migration Crisis. Politics in Central Europe. 2023. doi:10.2478/pce-2023-0001
BibTeX
@article{Ismayilzada2023,
author = {Ismayilzada, Tofig},
title = {The Populist Discourse of the Hungarian Prime Minister: The Case Study of Gyöngyöspata and Migration Crisis},
journal = {Politics in Central Europe},
year = {2023},
doi = {10.2478/pce-2023-0001}
}
EUVIMED